Advertisement
Singapore markets close in 1 hour 42 minutes

  • Straits Times Index

    3,301.53
    +8.60 (+0.26%)
     

  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     

  • Hang Seng

    18,575.67
    +99.75 (+0.54%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Bitcoin USD

    64,221.56
    +689.55 (+1.09%)
     

  • CMC Crypto 200

    1,370.95
    +58.33 (+4.44%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • Dow

    38,675.68
    +449.98 (+1.18%)
     

  • Nasdaq

    16,156.33
    +315.33 (+1.99%)
     

  • Gold

    2,322.10
    +13.50 (+0.58%)
     

  • Crude Oil

    78.72
    +0.61 (+0.78%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • FTSE Bursa Malaysia

    1,597.03
    +7.44 (+0.47%)
     

  • Jakarta Composite Index

    7,173.88
    +39.16 (+0.55%)
     

  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

Ionis to present at upcoming investor conferences

PR Newswire
·1-min read

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024

  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024

  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024

  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

ADVERTISEMENT

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.